Your browser doesn't support javascript.
loading
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Glitza Oliva, Isabella C; Ferguson, Sherise D; Bassett, Roland; Foster, Alexandra P; John, Ida; Hennegan, Tarin D; Rohlfs, Michelle; Richard, Jessie; Iqbal, Masood; Dett, Tina; Lacey, Carol; Jackson, Natalie; Rodgers, Theresa; Phillips, Suzanne; Duncan, Sheila; Haydu, Lauren; Lin, Ruitao; Amaria, Rodabe N; Wong, Michael K; Diab, Adi; Yee, Cassian; Patel, Sapna P; McQuade, Jennifer L; Fischer, Grant M; McCutcheon, Ian E; O'Brien, Barbara J; Tummala, Sudhakar; Debnam, Matthew; Guha-Thakurta, Nandita; Wargo, Jennifer A; Burton, Elizabeth M; Tawbi, Hussein A; Davies, Michael A.
Afiliación
  • Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. icglitza@mdanderson.org.
  • Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bassett R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Foster AP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • John I; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hennegan TD; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rohlfs M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Richard J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Iqbal M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dett T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lacey C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jackson N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Phillips S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Haydu L; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Amaria RN; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fischer GM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McCutcheon IE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • O'Brien BJ; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tummala S; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Debnam M; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guha-Thakurta N; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wargo JA; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tawbi HA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Med ; 29(4): 898-905, 2023 04.
Article en En | MEDLINE | ID: mdl-36997799
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Melanoma Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Melanoma Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos